Home Applications 022254 Application 022254
Type NDA
Sponsor UCB INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 VIMPAT LACOSAMIDE SOLUTION;INTRAVENOUS 200MG/20ML (10MG/ML) Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022254-001 VIMPAT LACOSAMIDE 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N022254-001 AP
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N022254-001 D-188 2026-04-28
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 45 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 c2088c7a36db…2026-09-14 22:38:34 2026-08 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 84e616aacf4f…2026-08-18 06:07:40 2026-07 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2008-10-28 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2008-10-28 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2008-10-28 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2008-10-28 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2008-10-28 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2008-10-28 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2008-10-28 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2008-10-28 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2008-10-28 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2008-10-28 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2008-10-28 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2008-10-28 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N022254-001 VIMPAT 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2008-10-28 3bdfa0b2c4d7…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 2 of 2 · 74 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2020-12-22 03:56 UTC 2020-12 N022254-001 RE38551 2022-03-17 U-2990 Drug substance, Drug product 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N022254-001 RE38551 2022-03-17 U-1568 Drug substance, Drug product c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N022254-001 RE38551 2022-03-17 U-1565 Drug substance, Drug product c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N022254-001 RE38551 2022-03-17 U-1568 Drug substance, Drug product 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N022254-001 RE38551 2022-03-17 U-1565 Drug substance, Drug product 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N022254-001 RE38551 2022-03-17 U-1568 Drug substance, Drug product b00525d2431f…2019-09-15 20:21 UTC 2019-09 N022254-001 RE38551 2022-03-17 U-1565 Drug substance, Drug product b00525d2431f…2019-07-19 19:46 UTC 2019-07 N022254-001 RE38551 2022-03-17 U-1568 Drug substance, Drug product ea99ee380514…2019-07-19 19:46 UTC 2019-07 N022254-001 RE38551 2022-03-17 U-1565 Drug substance, Drug product ea99ee380514…2023-01-26 05:58 UTC 2023-01 N022254-001 RE38551 2022-03-17 U-1565 Drug substance, Drug product 3bdfa0b2c4d7…2023-01-26 05:58 UTC 2023-01 N022254-001 RE38551 2022-03-17 U-2999 Drug substance, Drug product 3bdfa0b2c4d7…2023-01-26 05:58 UTC 2023-01 N022254-001 RE38551 2022-03-17 U-2989 Drug substance, Drug product 3bdfa0b2c4d7…2023-01-26 05:58 UTC 2023-01 N022254-001 RE38551 2022-03-17 U-2990 Drug substance, Drug product 3bdfa0b2c4d7…2023-01-26 05:58 UTC 2023-01 N022254-001 RE38551 2022-03-17 U-1568 Drug substance, Drug product 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N022254-001 RE38551 2022-03-17 U-1565 Drug substance, Drug product 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N022254-001 RE38551 2022-03-17 U-2999 Drug substance, Drug product 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N022254-001 RE38551 2022-03-17 U-2989 Drug substance, Drug product 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N022254-001 RE38551 2022-03-17 U-2990 Drug substance, Drug product 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N022254-001 RE38551 2022-03-17 U-1568 Drug substance, Drug product 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N022254-001 RE38551 2022-03-17 U-1565 Drug substance, Drug product f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 N022254-001 RE38551 2022-03-17 U-2999 Drug substance, Drug product f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 N022254-001 RE38551 2022-03-17 U-2989 Drug substance, Drug product f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 N022254-001 RE38551 2022-03-17 U-2990 Drug substance, Drug product f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 N022254-001 RE38551 2022-03-17 U-1568 Drug substance, Drug product f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N022254-001 RE38551 2022-03-17 U-1565 Drug substance, Drug product e64feba35796…2022-09-29 23:25 UTC 2022-09 N022254-001 RE38551 2022-03-17 U-2999 Drug substance, Drug product e64feba35796…2022-09-29 23:25 UTC 2022-09 N022254-001 RE38551 2022-03-17 U-2989 Drug substance, Drug product e64feba35796…2022-09-29 23:25 UTC 2022-09 N022254-001 RE38551 2022-03-17 U-2990 Drug substance, Drug product e64feba35796…2022-09-29 23:25 UTC 2022-09 N022254-001 RE38551 2022-03-17 U-1568 Drug substance, Drug product e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N022254-001 RE38551 2022-03-17 U-1568 Drug substance, Drug product cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N022254-001 RE38551 2022-03-17 U-2990 Drug substance, Drug product cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N022254-001 RE38551 2022-03-17 U-2989 Drug substance, Drug product cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N022254-001 RE38551 2022-03-17 U-2999 Drug substance, Drug product cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N022254-001 RE38551 2022-03-17 U-1565 Drug substance, Drug product cb3db0bc1861…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 3 · 86 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 11 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0131-1810 Vimpat lacosamide UCB, Inc. NDA Current 0131-1810 Vimpat lacosamide UCB, Inc. NDA Current 0131-1810 Vimpat lacosamide UCB, Inc. NDA Current 0131-1810 Vimpat lacosamide UCB, Inc. NDA Current 0131-1810 Vimpat lacosamide UCB, Inc. NDA Current 0131-1810 Vimpat lacosamide UCB, Inc. NDA Current 0131-1810 Vimpat lacosamide UCB, Inc. NDA Current 0131-1810 Vimpat lacosamide UCB, Inc. NDA Current 0131-1810 Vimpat lacosamide UCB, Inc. NDA Current 0131-1810 Vimpat lacosamide UCB, Inc. NDA Current 0131-1810 Vimpat lacosamide UCB, Inc. NDA Current